Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. - Wikidata - wikimedia - TriplyDB

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

http://www.wikidata.org/entity/Q45863191

about

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model.Impact of tumor microenvironment on oncolytic viral therapy Molecular imaging of metastatic potential.Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.Immune cells: more than simple carriers for systemic delivery of oncolytic viruses.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.Increasing the efficacy of oncolytic adenovirus vectors Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.Polymeric oncolytic adenovirus for cancer gene therapy.Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.Relaxin treatment of solid tumors: effects on electric field-mediated gene delivery.3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers Toward a stem cell gene therapy for breast cancer.Adenoviral virotherapy for malignant brain tumors Advances in oncolytic virus therapy for glioma.Armed replicating adenoviruses for cancer virotherapy.The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography Relaxin Modulates the Expression of MMPs and TIMPs in Fibroblasts of Patients with Carpal Tunnel Syndrome."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Oncolytic (replication-competent) adenoviruses as anticancer agents.Immunotherapeutic potential of oncolytic vaccinia virus.Oncolytic viruses: do they have a role in anti-cancer therapy?

P2860

Q24614856-6928F731-B55D-48D7-9E80-A1B124A4AF64 Q28756592-6F2DD9C3-BA1D-49F0-A36C-E4837BA4B9E6 Q33425253-92FC5C69-E7A6-4833-B48F-56FE2C3FDB3A Q33700061-8A01942F-78DD-4A5E-A4CD-D63AE536DA2A Q33895533-0F149D25-CC4F-47A7-9937-8A8AC518E1BA Q33917943-79019010-8C5F-4A42-AA22-EFAB98A48BF4 Q33931640-B9D57216-48FD-44F5-8804-2735DDDD3F17 Q34025129-3D42ADB7-F57B-4A2B-B518-ECD69E88BB9E Q34392057-0E7435D9-E20A-4B93-B066-1152F57C1D46 Q34582878-DAABDEA0-95F9-4B9C-924B-1D987DF1B46C Q34621713-CE4A2D49-02EC-424C-AD50-46A71385175E Q34959758-0D131C34-CF53-406F-94FA-220C6B9B89AA Q35119552-BA918DB1-4734-4E54-9BCE-5D50E3ECF200 Q35162284-C189D7D5-DA9F-43B0-A6AC-61B4E8248850 Q35210355-54997520-AF32-482D-AD74-BA7B15EB832C Q35223458-10EF5B18-BABA-4F7F-AF25-B2D9966E901D Q35261325-8C3CF23F-3D2C-4C2D-AB3A-4C8454A7E6FD Q35624010-237DD9B8-7CAA-429C-B7A4-26FFD5C4A8E9 Q35800342-AE063151-C755-4F9D-956D-798C0E411D4C Q36237474-149165B6-8642-492D-B00F-C289BC0B6D6D Q36298634-FB8AEBD2-6C1D-4633-A487-0D5044AE0782 Q36344901-A324C6B8-77F8-42CF-B2E1-F5A71213A1C7 Q36634430-DC74D69F-72B7-478D-BF2D-24E883E16F77 Q36751597-7B82CD07-2E7F-46F2-B5F6-F55F84715957 Q36803827-D6293583-3EFB-4165-9D20-0783137C24B1 Q36922264-7AA007D7-5989-4A03-AB87-64E2E29D1AF5 Q36951268-A82F9619-0DB8-44BF-BB90-EA9766CA16B2 Q37000549-FD33C4B3-46B9-4517-9CDC-8395CFDABA3B Q37120582-F0FE3B96-C30E-4BC6-9600-CEE26095A7B0 Q37209024-382CC16A-ABBB-4F4C-904A-2E2301DEE63A Q37223846-BC17915B-7EBE-48AE-BEB9-C085BB60416B Q37287118-502DBE47-DD60-4364-AE82-D7D319243195 Q37386616-5E132320-1995-41D6-9C5A-61448531F738 Q37459624-5A971BD5-D059-4826-8983-6AC69CFB5E6F Q37594715-C641801D-71DA-49AC-90D6-405169A71D46 Q37622174-AF0219A5-9B7F-42B3-BE20-B5813E678CEC Q37622288-B445CF75-BA76-41CD-BDE4-1A75FF8C3D4E Q37687415-506C6B68-06B8-4C85-A8A9-4BF76211EF6D Q37895969-1A9B4F0D-C5E1-4B6F-BCC1-1BDCEA69A90B Q37926486-71366304-2023-41AA-8223-5C5BCF0291BA

P2860

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

http://www.wikidata.org/entity/Q45863191

description

2006 nî lūn-bûn

@nan

2006 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@en

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@nl

type

label

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@en

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@nl

prefLabel

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@en

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@nl

P1433

Q45863191-BC48ECD9-6D51-4A1A-BF94-C5080DACCAA6

P1476

Q45863191-3677F323-935B-432E-97A7-BEB614E41DCC

P2093

Q45863191-1DB45DFA-A7DC-44F8-B12A-86467AFA949F

Q45863191-76DF33F0-9874-4F93-AEA3-6CE8BCB56D58

Q45863191-A3D527B1-18A2-444B-8AE8-6B854348D060

Q45863191-ACCAA49D-7B3E-4245-A625-8CA7F7EEFDA3

Q45863191-CD710531-C9EA-46EE-9634-0D9D319793D6

P2860

Q45863191-072269E5-6FEC-43F0-9DCE-440C5256EA31

Q45863191-0F110640-79B9-4DBB-B0F5-0944A47D0A63

Q45863191-128DD6E9-C20E-4B34-8A60-0FA2603DADB5

Q45863191-1517CCCD-4220-4DA9-9708-0D5D1E464745

Q45863191-223E69B5-B198-4718-BAA5-29292235D33F

Q45863191-3ECDBC5B-65D4-4765-A9AB-EBC705B458D0

Q45863191-4E2BB4AC-3950-445D-9F73-D467BF5B27BB

Q45863191-58793AE0-BF86-4D74-B2E1-22E563040C8A

Q45863191-5D5B14E1-7450-4BB7-ADD4-4B4FB04D8F63

Q45863191-8648333A-58AF-40C4-819D-E12AD5AF9303

P304

Q45863191-B8336621-2A11-45D8-A6C1-2264100117CB

P31

Q45863191-5F8C4BC0-EDAF-47B6-856E-FB61C5710C62

P356

Q45863191-948B2B51-EEAF-4DAF-93C9-84C911BD385B

P407

Q45863191-55BC3636-A683-4F84-97E1-1F310C395AE9

P433

Q45863191-A144C707-CE5C-4DDA-A072-3284FFD9E5B1

P478

Q45863191-857FCEBA-E658-4B33-B1F0-D6C6CD132C3E

P50

Q45863191-AC5EB6B7-DC82-422C-B07B-16069503AE98

P577

Q45863191-53E29718-CB78-4F6B-90E5-636EB0E91FB7

P5875

Q45863191-423C94D4-EBA6-4651-81F2-7AFE7E079176

P698

Q45863191-6FC6D777-BE71-4CF5-A82E-60493B941148

P921

Q45863191-D6D7B861-14AA-45CF-907C-10D815B9F757

P356

P1433

Journal of the National Cancer Institute

P1476

Relaxin expression from tumor- ...... tosis induction, and efficacy.

@en

P2093

A-Rum Yoon

http://www.w3.org/2001/XMLSchema#string

Hoguen Kim

http://www.w3.org/2001/XMLSchema#string

Jing-Hua Huang

http://www.w3.org/2001/XMLSchema#string

Joo-Hang Kim

http://www.w3.org/2001/XMLSchema#string

Young-Sook Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of orphan receptors by the hormone relaxin

INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent

Cancer gene therapy: hard lessons and new courses.

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

Hormone families: pancreatic hormones and homologous growth factors.

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.

Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis.

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.

P304

1482-1493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ397

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6748824

http://www.w3.org/2001/XMLSchema#string

P698

17047197

http://www.w3.org/2001/XMLSchema#string

P921